Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Nicoletti

Showing results (391-400 of 548) with videos related to

Pageof 55
Sort By:
Stroke|February 18, 2026
Targeted Inhibition of mGlu5 Receptors in the Contralesional Hemisphere Improves Functional Recovery After StrokeFederica Mastroiacovo, Serena Notartomaso, Slovianka Moyanova, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cellsFlorian Rothweiler, Martin Michaelis, Peter Brauer, et al.
Life (Basel, Switzerland)|March 25, 2022
Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in MiceAna Elena Teleuca, Giovanni Sebastiano Alemà, Paola Casolini, et al.
Frontiers in Psychiatry|March 21, 2019
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in SchizophreniaFerdinando Nicoletti, Rosamaria Orlando, Luisa Di Menna, et al.
Cell Cycle (Georgetown, Tex.)|January 29, 2011
In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cellsMarco Donia, Danijela Maksimovic-Ivanic, Sanja Mijatovic, et al.
Journal of Cellular Physiology|April 5, 2014
Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse modelsKatia Mangano, Paolo Fagone, Klaus Bendtzen, et al.
Frontiers in Pharmacology|November 10, 2016
Fluoxetine Prevents Aβ<sub>1-42</sub>-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1Filippo Caraci, Fabio Tascedda, Sara Merlo, et al.
Journal of Cellular Physiology|December 8, 2007
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitusStanislava Stosic-Grujicic, Ivana Stojanovic, Danijela Maksimovic-Ivanic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 11, 2006
Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomasLuisa Iacovelli, Antonietta Arcella, Giuseppe Battaglia, et al.
Free Radical Biology & Medicine|February 2, 2010
Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NOSanja Mijatovic, Danijela Maksimovic-Ivanic, Gordana Timotijevic, et al.
Pageof 55

Showing results (391-400 of 548) with videos related to

Sort By:
Pageof 55
Stroke|February 18, 2026
Targeted Inhibition of mGlu5 Receptors in the Contralesional Hemisphere Improves Functional Recovery After StrokeFederica Mastroiacovo, Serena Notartomaso, Slovianka Moyanova, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cellsFlorian Rothweiler, Martin Michaelis, Peter Brauer, et al.
Life (Basel, Switzerland)|March 25, 2022
Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in MiceAna Elena Teleuca, Giovanni Sebastiano Alemà, Paola Casolini, et al.
Frontiers in Psychiatry|March 21, 2019
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in SchizophreniaFerdinando Nicoletti, Rosamaria Orlando, Luisa Di Menna, et al.
Cell Cycle (Georgetown, Tex.)|January 29, 2011
In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cellsMarco Donia, Danijela Maksimovic-Ivanic, Sanja Mijatovic, et al.
Journal of Cellular Physiology|April 5, 2014
Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse modelsKatia Mangano, Paolo Fagone, Klaus Bendtzen, et al.
Frontiers in Pharmacology|November 10, 2016
Fluoxetine Prevents Aβ<sub>1-42</sub>-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1Filippo Caraci, Fabio Tascedda, Sara Merlo, et al.
Journal of Cellular Physiology|December 8, 2007
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitusStanislava Stosic-Grujicic, Ivana Stojanovic, Danijela Maksimovic-Ivanic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 11, 2006
Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomasLuisa Iacovelli, Antonietta Arcella, Giuseppe Battaglia, et al.
Free Radical Biology & Medicine|February 2, 2010
Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NOSanja Mijatovic, Danijela Maksimovic-Ivanic, Gordana Timotijevic, et al.
Pageof 55